February 6, 2006
Hickey Elected Fellow by American Association for the Advancement of Science
By Jim Walsh
UNC News Services
Anthony Hickey, PhD, has been elected as a fellow of the American Association for the Advancement of Science for his efforts to advance science or its applications. He, along with the other 375 fellows for 2005, will be recognized for their contributions at a February 18 forum during the AAAS annual meeting.
The AAAS, a nonprofit organization, seeks to advance science worldwide by serving as an educator, leader, spokesperson and professional association. The association publishes the journal Science, in addition to newsletters, books, and reports.
Hickey, a molecular pharmaceutics and bioengineering professor, was recognized for his research on delivering medicines to the lungs and the development of devices to aid in that delivery.
Hickey joined the UNC faculty in 1993. He has been elected a fellow of the Institute of Biology of the United Kingdom and the American Association of Pharmaceutical Scientists. He supervises a multidisciplinary group of engineers and scientists who study aerosol drug delivery to the lungs, and he collaborates with the nonprofit group Medicine in Need, a research organization based at Harvard University.
He is president and chief executive officer of Cirrus Pharmaceuticals Inc. and chief scientific officer of Oriel Therapeutics Inc., an emerging inhaled drug delivery company that uses technology developed at UNC. Oriel recently reported that inventions central to its dry powder inhaler technology have been granted a U.S. patent.
Thirty-two UNC faculty members have been elected fellows of the AAAS.
For the full story, please click here.